Long-term improvement under deferiprone in a case of neurodegeneration with brain iron accumulation

Selective iron chelation in Friedreich ataxia: biologic and clinical implications

Boddaert, N., Le Quan Sang, K. H., Rötig, A., Leroy-Willig, A., Gallet, S., Brunelle, F., Sidi, D., Thalabard, J.-C., Munnich, A., & Cabantchik, Z. I. (2007) · Blood · doi:10.1182/blood-2006-12-065433 · Cited by 409 · see citing works

Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation

Chinnery, P. F., Crompton, D. E., Birchall, D., Jackson, M. J., Coulthard, A., Lombes, A., Quinn, N., Wills, A., Fletcher, N., Mottershead, J. P., et al. (2006) · Brain · doi:10.1093/brain/awl319 · Cited by 205 · see citing works

The pharmacokinetics and blood-brain barrier permeation of the chelators 1,2 dimethyl-, 1,2 diethyl-, and 1-[ethan-1′ ol]-2-methyl-3-hydroxypyridin-4-one in the rat

Fredenburg, A. M., Sethi, R. K., Allen, D. D., & Yokel, R. A. (1996) · Toxicology · doi:10.1016/0300-483x(95)03301-u · Cited by 94 · see citing works

Advances in iron chelation: an update

Heli, H., Mirtorabi, S., & Karimian, K. (2011) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.569493 · Cited by 92 · see citing works

Regression of symptoms after selective iron chelation therapy in a case of neurodegeneration with brain iron accumulation

Forni, G. L., Balocco, M., Cremonesi, L., Abbruzzese, G., Parodi, R. C., & Marchese, R. (2008) · Movement Disorders · doi:10.1002/mds.22002 · Cited by 80 · see citing works

The role of iron in brain ageing and neurodegenerative disorders

Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R., & Zecca, L. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70117-6 · Cited by 1,819 · see citing works

Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics

Belaidi, A. A., & Bush, A. I. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13425 · Cited by 580 · see citing works

Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases

Chen, L., Shen, Q.-Q., Liu, Y.-J., Zhang, Y., Sun, L., Ma, X.-Z., Song, N., & Xie, J.-X. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02071-0 · Cited by 261 · see citing works

Iron dysregulation in movement disorders

Dušek, P., Jankovic, J. J., & Le, W. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.054 · Cited by 172 · see citing works

Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms

Levi, S., & Finazzi, D. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00099 · Cited by 164 · see citing works

Epigallocatechin Gallate Has a Neurorescue Effect in a Mouse Model of Parkinson Disease

Xu, Q., Langley, M. R., Kanthasamy, A. G., & Reddy, M. B. (2017) · Journal of Nutrition · doi:10.3945/jn.117.255034 · Cited by 156 · see citing works

Genetics and Pathophysiology of Neurodegeneration with Brain Iron Accumulation (NBIA)

Schneider, S. A., Dušek, P., Hardy, J., Westenberger, A., Jankovic, J. J., & Bhatia, K. P. (2013) · Current Neuropharmacology · doi:10.2174/157015913804999469 · Cited by 140 · see citing works

Iron chelation in the treatment of neurodegenerative diseases

Dušek, P., Schneider, S. A., & Aaseth, J. (2016) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2016.03.010 · Cited by 133 · see citing works

Neurodegenerative diseases and therapeutic strategies using iron chelators

Ward, R. J., Dexter, D. T., & Crichton, R. R. (2015) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2014.12.012 · Cited by 121 · see citing works

Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): Results from a four years follow-up

Cossu, G., Abbruzzese, G., Matta, G., Murgia, D., Melis, M., Ricchi, V., Galanello, R., Barella, S., Origa, R., Balocco, M., et al. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.03.002 · Cited by 93 · see citing works

Neurodegeneration with Brain Iron Accumulation Disorders Overview

Gregory, A., & Hayflick, S. J. (2014) · University of Washington, Seattle eBooks · Cited by 93 · see citing works

Regional siderosis: a new challenge for iron chelation therapy

Cabantchik, Z. I., Münnich, A., Youdim, M. B. H., & Devos, D. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00167 · Cited by 67 · see citing works

Iron chelation and multiple sclerosis

Weigel, K. J., Lynch, S. G., & LeVine, S. M. (2014) · ASN NEURO · doi:10.1042/an20130037 · Cited by 63 · see citing works

Ageing neuroinflammation and neurodegeneration

Ward, R. J. (2015) · Frontiers in Bioscience-Scholar · doi:10.2741/s433 · Cited by 63 · see citing works

Neuroferritinopathy: a new inborn error of iron metabolism

Keogh, M. J., Jonas, P., Coulthard, A., Chinnery, P. F., & Burn, J. (2012) · Neurogenetics · doi:10.1007/s10048-011-0310-9 · Cited by 49 · see citing works

Neurodegeneration with brain iron accumulation

Dusek, P., & Schneider, S. A. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283550cac · Cited by 39 · see citing works

Coenzyme a Biochemistry: From Neurodevelopment to Neurodegeneration

Mignani, L., Gnutti, B., Zizioli, D., & Finazzi, D. (2021) · Brain Sciences · doi:10.3390/brainsci11081031 · Cited by 38 · see citing works

Repositioning and development of new treatments for neurodegenerative diseases: Focus on neuroinflammation

Arbo, B. D., Schimith, L. E., dos Santos, M. G., & Hort, M. A. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174800 · Cited by 33 · see citing works

Increased brain iron deposition in patients with sickle cell disease: an MRI quantitative susceptibility mapping study

Miao, X., Choi, S., Tamrazi, B., Chai, Y., Vu, C. Q., Coates, T. D., & Wood, J. C. (2018) · Blood · doi:10.1182/blood-2018-04-840322 · Cited by 24 · see citing works

Cardioprotective Potential of Iron Chelators and Prochelators

Jansová, H., & Šimůnek, T. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867324666170920155439 · Cited by 21 · see citing works

Current Concepts and Controversies in Neurodegeneration with Brain Iron Accumulation

Keogh, M. J., & Chinnery, P. F. (2012) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2012.03.004 · Cited by 20 · see citing works

Towards Precision Therapies for Inherited Disorders of Neurodegeneration with Brain Iron Accumulation

Spaull, R., Soo, A. K. S., Hogarth, P., Hayflick, S. J., & Kurian, M. A. (2021) · Tremor and Other Hyperkinetic Movements · doi:10.5334/tohm.661 · Cited by 20 · see citing works

NBIA Syndromes: A Step Forward from the Previous Knowledge

Svetel, M. V., Dragašević, N., Petrović, I. N., Novaković, I. V., Tomić, A., Kresojević, N. D., Stanković, I., & Kostić, V. (2021) · Neurology India · doi:10.4103/0028-3886.329603 · Cited by 19 · see citing works

Deferasirox, an Iron‐Chelating Agent, Improves Testicular Morphometric and Sperm Functional Parameters in a Rat Model of Varicocele

Rahmani, M., Tavalaee, M., Hosseini, M., Eskandari, A., Shaygannia, E., Sadeghi, N., Nazem, M. N., Gharagozloo, P., Drevet, J. R., & Nasr‐Esfahani, M. H. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6698482 · Cited by 18 · see citing works

Therapeutic Advances in Neurodegeneration With Brain Iron Accumulation

Zorzi, G. S., Zibordi, F., Chiapparini, L., & Nardocci, N. (2012) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2012.03.007 · Cited by 14 · see citing works

Diagnostics and Treatments of Iron-Related CNS Diseases

Xiong, H., Tuo, Q., Guo, Y., & Lei, P. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9589-5_10 · Cited by 14 · see citing works

Effective R2 relaxation rate, derived from dual-contrast fast-spin-echo MRI, enables detection of hemisphere differences in iron level and dopamine function in Parkinson’s disease and healthy individuals

Luo, J., & Collingwood, J. F. (2022) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2022.109708 · Cited by 13 · see citing works

Therapeutic Advances in Neurodegeneration with Brain Iron Accumulation

Zorzi, G. S., & Nardocci, N. (2013) · International review of neurobiology · doi:10.1016/b978-0-12-410502-7.00008-9 · Cited by 13 · see citing works

2,6-Dihydroxybenzaldehyde Analogues of the Iron Chelator Salicylaldehyde Isonicotinoyl Hydrazone: Increased Hydrolytic Stability and Cytoprotective Activity against Oxidative Stress

Jansová, H., Kubeš, J., Reimerová, P., Štěrbová‐Kovaříková, P., Roh, J., & Šimůnek, T. (2018) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00165 · Cited by 11 · see citing works

Etiology and Pathogenesis of Parkinson’s Disease

Timpka, J., Cenci, M. A., & Odin, P. (2017) · Springer eBooks · doi:10.1007/978-3-7091-1628-9_10 · Cited by 8 · see citing works

Neurodegeneration with Brain Iron Accumulation

Nardocci, N., Cavallera, V., Chiapparini, L., & Zorzi, G. S. (2014) · Springer eBooks · doi:10.1007/978-1-4471-6455-5_10 · Cited by 5 · see citing works

Chelating Therapy in Metal Storage Diseases

Dušek, P., & Aaseth, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803072-1.00006-7 · Cited by 5 · see citing works

Deferiprone-induced seizures in a patient with β-thalassemia major

Mallat, N. S., Beydoun, A. A., Musallam, K. M., Koussa, S., & Taher, A. T. (2013) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2013.03.002 · Cited by 3 · see citing works

Treatment of Neurodegenerative Diseases by Chelators

Ward, R. J., Dexter, D. T., & Crichton, R. R. (2016) · Royal Society of Chemistry eBooks · doi:10.1039/9781782623892-00153 · Cited by 2 · see citing works

Pathometallomics: Taking Neurodegenerative Disease as an Example

Du, X., Li, X., & Liu, Q. (2024) · Wiley eBooks · doi:10.1002/9783527840397.ch10 · Cited by 1 · see citing works

Therapeutic Strategies to Combat the Onset and Progression of Neurological Diseases

Crichton, R. R., & Ward, R. J. (2013) · Wiley eBooks · doi:10.1002/9781118553480.ch14

Emerging Therapeutic Approaches for Neurodegenerative Diseases

Ugale, R. R., & Sarode, L. P. (2022) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815040913122010013

PLA2G6-Associated Neurodegeneration: A Rare Case Report of Neurodegeneration with Brain Iron Accumulation in Children

Widianti, N., Hanindita, M. H., Widjaja, N. A., & Irawan, R. (2022) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.39.1.6801

Iron and Multiple Sclerosis

Anika, & Arora, R. (2022) · Nutritional neurosciences · doi:10.1007/978-981-19-7327-7_8

Pathophysiology, biological models and new therapeutic approaches in β-Propeller Associated Neurodegeneration

Romero-González, A., Reche-López, D., Álvarez-Córdoba, M., Suárez-Carrillo, A., Cilleros-Holgado, P., Piñero-Pérez, R., Gómez-Fernández, D., Romero-Domínguez, J. M., López-Cabrera, A., & Sánchez-Alcázar, J. A. (2025) · International review of cytology · doi:10.1016/bs.ircmb.2025.10.004

Development of chelating materials for localized metal extraction in neurodegenerative diseases

Ariza, J. F. S. (2024) · theses.fr (ABES) · doi:10.70675/f7b37b1dz1608z4009zae5cz453748e7aaaf

A pilot trial of\ndeferiprone for neurodegeneration with brain iron accumulation

Abbruzzese, G., Cossu, G., Balocco, M., Marchese, R., Murgia, D., Melis, M., Galanello, R., Barella, S., Matta, G., Ruffinengo, U., et al. (2011) · CINECA IRIS Institutial research information system (University of Pisa)

Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): Results from a four years follow-up

Cossu, G., Abbruzzese, G., Matta, G., Murgia, D., Melis, M., Ricchi, V., Galanello, R., Barella, S., Origa, R., Balocco, M., et al. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.03.002 · Cited by 93 · see citing works

An international trial of deferiprone in patients with Parkinson’s disease

Gb, E. (2019) · doi:10.1002/central/cn-01847548

A pilot clinical trial with the iron chelator Deferiprone in Parkinson's disease - Pilot clinical trial iron chelator Deferiprone in Parkinson's Vs1

Gb, E. (2019) · doi:10.1002/central/cn-01846040

A pilot trial of deferiprone for neurodegeneration with brain iron accumulation

Abbruzzese, G., Cossu, G., Balocco, M., Marchese, R., Murgia, D., Melis, M., Galanello, R., Barella, S., Matta, G., Ruffinengo, U., et al. (2011) · Haematologica · doi:10.3324/haematol.2011.043018 · Cited by 131 · see citing works